Browse Category

Stock Market News 31 December 2025

AppLovin (NASDAQ: APP) stock dips today as year-end tech pullback pressures growth names

AppLovin (NASDAQ: APP) stock dips today as year-end tech pullback pressures growth names

NEW YORK, December 31, 2025, 14:13 ET — Regular session AppLovin Corp shares fell 1.3% to $685.00 in afternoon trading on Wednesday. The stock ranged between $682.73 and $698.23. The move tracked a modest dip in major U.S. indexes in the final trading session of 2025, with technology shares among the biggest drags as holiday-thinned liquidity amplified small swings. Reuters Treasury yields ticked higher after new data showed jobless claims fell to 199,000 in the week ended Dec. 27, undershooting economists’ expectations for a rise. Higher yields raise the discount rate investors use to value future profits, a headwind for
Applied Digital (APLD) climbs on fresh analyst calls as ChronoScale spin-off plan stays in focus

Applied Digital (APLD) climbs on fresh analyst calls as ChronoScale spin-off plan stays in focus

NEW YORK, December 31, 2025, 14:00 ET — Regular session Applied Digital Corporation shares rose about 4.6% to $25.20 in afternoon trading on Wednesday, after a burst of upbeat analyst coverage ahead of the company’s earnings next week. Northland Capital Markets analyst Mike Grondahl maintained an Outperform rating with a $40 price target, while Lake Street analyst Rob Brown reiterated a Buy rating and kept a $45 target, Benzinga reported. Northland also named Applied Digital its top pick for 2026, citing demand for power from hyperscalers — the largest cloud providers — and a potential move toward a REIT, or
Corcept Therapeutics (CORT) stock dives nearly 50% after FDA rejects relacorilant — what investors watch next

Corcept Therapeutics (CORT) stock dives nearly 50% after FDA rejects relacorilant — what investors watch next

NEW YORK, December 31, 2025, 13:58 ET — Regular session Shares of Corcept Therapeutics Incorporated (CORT.O) sank nearly 50% on Wednesday after the U.S. Food and Drug Administration issued a complete response letter for the company’s relacorilant application in hypertension secondary to hypercortisolism, also known as Cushing’s syndrome. The stock was down 49.7% at $35.31 in afternoon trading. Nasdaq The decision lands at a sensitive moment for investors who had been looking to relacorilant as the company’s next product story in Cushing’s beyond its marketed therapy. “FDA’s request for additional data may require additional trials, significantly dimming Corcept’s outlook in
Santa Claus Rally Fizzles: S&P 500, Dow Slip as Tech Weighs on 2025 Finale

Santa Claus Rally Fizzles: S&P 500, Dow Slip as Tech Weighs on 2025 Finale

NEW YORK, December 31, 2025, 13:55 ET Wall Street’s main indexes inched lower in the final trading session of 2025, pressured by technology shares, but remained on track to finish the year with solid gains. The late-year dip matters because it comes after a volatile year shaped by tariff uncertainty from President Donald Trump and a powerful run in artificial intelligence, or AI, stocks that pushed major indexes to record highs. It also puts a spotlight on the market’s failure to deliver a “Santa Claus rally” — the seasonal pattern when the S&P 500 often rises over the last five
JPMorgan stock edges up in thin year-end trade as Fed minutes and funding markets steer banks

JPMorgan stock edges up in thin year-end trade as Fed minutes and funding markets steer banks

NEW YORK, December 31, 2025, 13:56 ET — Regular session JPMorgan Chase & Co (JPM.N) shares were up 0.3% at $324.25 in afternoon trading on Wednesday, moving in a narrow range in the final U.S. equity session of 2025. The muted move matters because big U.S. banks are heading into January with two rate-sensitive crosscurrents: a Federal Reserve that has started cutting but remains divided on how much more, and a year-end squeeze in short-term funding markets. For JPMorgan, the direction of rates can quickly show up in results. Higher market yields can support net interest income — the gap
AST SpaceMobile (ASTS) stock slips today as insider buy filing, AT&T satellite update keep launch focus

AST SpaceMobile (ASTS) stock slips today as insider buy filing, AT&T satellite update keep launch focus

NEW YORK, December 31, 2025, 13:57 ET — Regular session AST SpaceMobile, Inc. (ASTS) shares were down 0.8% at $74.05 in early afternoon trading on Wednesday, after swinging between $72.53 and $75.73. The Nasdaq-tracking Invesco QQQ was off about 0.2%. The pullback matters because AST’s valuation has become tightly linked to a handful of near-term execution checkpoints: satellite launches, ground network buildout and carrier readiness. Those milestones can move the stock even when the broader market is quiet. The company is trying to deliver “direct-to-device” connectivity — linking satellites to standard smartphones without specialized equipment — and investors are watching
BitMine Immersion (BMNR) stock slips today as SEC filing flags $13.2B crypto stash and Jan. 15 vote

BitMine Immersion (BMNR) stock slips today as SEC filing flags $13.2B crypto stash and Jan. 15 vote

NEW YORK, December 31, 2025, 13:54 ET — Regular session Shares of BitMine Immersion Technologies, Inc. fell about 1.5% to $27.30 on Wednesday, giving back early gains as investors weighed the company’s latest proxy-related disclosures and choppy year-end crypto trading. SEC The stock has become a fast-moving proxy for ether prices, after BitMine pivoted toward building a large cryptocurrency “treasury” — a balance-sheet strategy where the company holds digital assets rather than treating them as a byproduct of operations. That linkage matters into the final two sessions of 2025, when liquidity can thin out and tax-driven repositioning tends to exaggerate
IREN stock slips in New York trade as bitcoin eases into year-end

IREN stock slips in New York trade as bitcoin eases into year-end

NEW YORK, December 31, 2025, 13:50 ET — Regular session IREN Limited shares fell about 1% on Wednesday to $37.92, paring earlier losses as the price of bitcoin drifted lower. The Nasdaq-listed company sits at the intersection of two volatile trades: bitcoin mining and data centers built for artificial intelligence workloads. That combination has made the stock sensitive to shifts in crypto prices and risk appetite. Reuters Moves late in the year can also be magnified by portfolio adjustments, as funds lock in gains or harvest losses before the calendar turns. “Some year-end rebalancing is going on,” Michael Dehal, senior
Eli Lilly stock today: LLY slips as China Mounjaro cuts and U.S. pricing reset draw focus

Eli Lilly stock today: LLY slips as China Mounjaro cuts and U.S. pricing reset draw focus

NEW YORK, December 31, 2025, 13:48 ET — Regular session Eli Lilly shares edged lower on Wednesday as investors weighed new signals that blockbuster diabetes and obesity drugs are heading into 2026 with lower price tags in some markets. The stock was down 0.1% at $1,078.95 by 1:48 p.m. ET, after trading between $1,076.86 and $1,083.25. The pricing debate matters for Lilly because its growth story is dominated by GLP-1 drugs, a class of diabetes and obesity treatments that mimic a gut hormone to curb appetite and lower blood sugar. Moves that broaden access can lift volumes, but price cuts
Heartflow stock drops nearly 3% today as year-end trading thins; what investors watch next

Heartflow stock drops nearly 3% today as year-end trading thins; what investors watch next

NEW YORK, December 31, 2025, 13:57 ET — Regular session Heartflow Inc shares fell 2.8% to $29.35 by early afternoon on Wednesday, after trading between $29.26 and $30.97. Volume was about 336,000 shares. The drop outpaced a small decline in the broader market, with the S&P 500 tracker SPY down about 0.2% and the Nasdaq 100 tracker QQQ off roughly 0.2%. The health-care sector ETF XLV dipped about 0.1%, while the U.S. medical devices ETF IHI fell about 0.3%. The move comes in a typically thin year-end session, with U.S. stock markets open for regular hours on New Year’s Eve
Sandisk stock today: SNDK dips as company sets Jan. 29 earnings date

Sandisk stock today: SNDK dips as company sets Jan. 29 earnings date

NEW YORK, December 31, 2025, 13:52 ET — Regular session Sandisk Corp shares were down 1.1% at $237.64 on Wednesday, after the flash-memory maker set Jan. 29 for its fiscal second-quarter results as year-end trading stayed thin. The stock has ranged from $235.54 to $241.69, while peers Western Digital, Micron Technology and Seagate Technology also traded lower and the broader market drifted modestly down. The timing matters because Sandisk has been one of 2025’s biggest winners, rising nearly 600% since returning to the market after being spun off from Western Digital earlier this year and joining the S&P 500 in
OneSpaWorld (OSW) stock slides nearly 3% today as year-end trading cools cruise-linked names

OneSpaWorld (OSW) stock slides nearly 3% today as year-end trading cools cruise-linked names

NEW YORK, December 31, 2025, 12:52 ET — Regular session OneSpaWorld Holdings Limited shares were last down 2.7% at $20.78 on Wednesday, after touching an intraday low of $20.78. The stock has traded between $20.78 and $21.51, with about 53,000 shares traded so far. The cruise-spa operator is often treated as a read-through on discretionary spending at sea. OneSpaWorld runs health and wellness centers on cruise ships and at destination resorts, and its annual report shows it served 199 ships at the end of 2024 under long-term contracts that average about five and a half years. SEC That linkage matters

Stock Market Today

Corning stock price hits record close — what’s driving GLW and the next big test

Corning stock price hits record close — what’s driving GLW and the next big test

7 February 2026
Corning shares jumped 8.3% to a record $122.16 Friday, gaining 11% over two sessions amid strong demand for AI infrastructure stocks. The move follows a $6 billion optical fiber deal with Meta and upgraded company forecasts. Shares traded as high as $122.56 and rose 0.6% after hours. COO Avery Nelson sold 1,894 shares for tax withholding, retaining 66,050.
PepsiCo stock: €2.5 billion bond deal lands as investors size up the price-cut gamble

PepsiCo stock: €2.5 billion bond deal lands as investors size up the price-cut gamble

7 February 2026
PepsiCo priced €2.5 billion in euro notes across four maturities, with settlement set for Feb. 11, according to an SEC filing. The company plans to use proceeds for general corporate purposes, including repaying commercial paper. Shares closed at $170.49 Friday, up 1.8%. PepsiCo is also cutting U.S. snack prices by up to 15% after consumer pushback.
Go toTop